Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
5 February 2019
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Cate today joined MIA Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, and CEO Matthew Browne on a tour of Melanoma Institute Australia in Sydney. Cate also met young mum Jenny Day and her three little girls who lost their dad and husband David to melanoma. They are one of four families bravely sharing their stories of loss for the 2019 Melanoma March campaign.
Melanoma Institute Australia CEO Matthew Browne says the organisation is delighted to have Cate Campbell onboard as the 26-year-old athlete’s own recent brush with melanoma compellingly demonstrates the importance of being sun-safe and aware of changes to your skin.
Cate embodies the Australian way of life and her love of the outdoors, be it swimming, hiking or kayaking, makes her an ideal National Ambassador for MIA,” Matthew said. “Many people don’t realise melanoma kills one Australian every five hours and is the most common cancer affecting 15 to 39 year olds. By having Cate onboard we will better be able to reach young Australians with sun-safety and skin awareness messages.
Cate went for a skin check in November 2018 after bumping into a friend who had a near miss with melanoma. Cate had a mole on her arm removed during the check, which turned out to be Stage I melanoma and required further surgery. It was her melanoma diagnosis that inspired her to become an advocate for the importance of sun safety and skin checks.
As Australians, we spend so much time in the sun and with melanoma the most common cancer in young Australians I want to make sure people know the importance of having skin checks,” said Cate. “As someone with pale, freckly skin, keeping up with freckles and sun spots is difficult, but my melanoma developed in a mole I had my whole life and on the surface it looked like nothing had changed. I shudder to think what would have happened had I not had that mole checked. It literally saved my life.”
Melanoma Institute Australia is leading global research efforts to find a cure for melanoma. Despite recent breakthroughs tripling life expectancy for many advanced melanoma patients, more research is needed into why some people just don’t respond, and also to determine how to tackle earlier stage disease.
To reach zero deaths from melanoma, we need to crack the riddle of so-called ‘super progressors’, like David Day, whose disease progresses rapidly despite these new treatments and they die within months” said Professor Georgina Long. “We also need to better understand how we can use these new treatments during earlier stage melanoma, to stop it spreading to vital organs in the first place,” added Professor Scolyer. Melanoma March raises money to enable such national collaborative research projects to find a cure for melanoma. This year there will be 23 family friendly Melanoma March events across the country, as well as the 2000km Jay’s Longest Melanoma March from Adelaide to Sydney.
"I will be joining the Melanoma March event in my home town of Brisbane as I know I was incredibly lucky, but for so many people diagnosed with melanoma this isn’t the case,” Cate said.
We need to keep encouraging Australians to prioritise sun safety and skin awareness as part of their health regime, and we need answers. To find those answers we need research, and that means raising much-needed research dollars through campaigns like Melanoma March.
Please join me in helping those Australians bravely battling for their lives, and supporting families like David Day’s who are left behind.”
For more information on how to register for a march near you or donate to Melanoma March, go to www.melanomamarch.org.au
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.